advertisement

WGA Rescources

11.3.3 Apraclonidine, brimonidine (9)

Showing records 1 to 9

Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine

Search within classification 11.3.3 Apraclonidine, brimonidine
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Mizoue S
Advances in Therapy 2017; 34: 1438-1448
72975 Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
Moschos MM; Moustafa GA
Drug design, development and therapy 2017; 11: 1267-1272
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Nitta K; Shirakashi M
Advances in Therapy 2017; 34: 1438-1448
72975 Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
Papakonstantinou VD; Tsatsos M
Drug design, development and therapy 2017; 11: 1267-1272
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Nitta A
Advances in Therapy 2017; 34: 1438-1448
72975 Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
Laios K
Drug design, development and therapy 2017; 11: 1267-1272
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Yamabayashi S
Advances in Therapy 2017; 34: 1438-1448
72975 Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
Antonopoulou S
Drug design, development and therapy 2017; 11: 1267-1272
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Advances in Therapy 2017; 34: 1438-1448

Issue 18-4

Change Issue


advertisement

Topcon